ChromaCure is seeking to discover and develop first-in-class small molecule therapeutics for unmet needs in oncology. The company will develop inhibitors of a novel target that is a key regulator of tumor initiation and progression.
Member count: 11-50
Investors 1
| Date | Name | Website |
| - | Newton Bio... | newtonbioc... |